The neurologist explains the link between Guillain-Barre Syndrome and paralysis, and the initial symptoms to watch out for.
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback